Three clinicians reviewing information together on a laptop at a clinic desk

AI in healthcare administration is often framed as replacement. Replace the coder. Replace the appeals writer. Replace the reviewer.

That framing is strategically flawed and operationally risky — and it is precisely the model that payers have already deployed against providers.

The right architecture is different. It is called human-in-the-loop AI. And for hospital leaders and independent practices navigating the denial crisis, understanding the distinction is a matter of margin protection and audit defensibility.

What Full Automation Gets Wrong

Automation without clinical judgment is how we got here.

Payers have spent years deploying algorithmic denial tools — and the results are well-documented in federal investigations, Senate inquiries, and HHS Office of Inspector General reports. Denial rates for Medicare Advantage plans have exceeded 20% at some major insurers, with physician override rates on appeal approaching 90% in documented cases — suggesting that automation optimized for denial, not accuracy.

The irony is that many AI vendors now pitch providers on the same model: fully automated appeal generation, zero human review, maximum throughput.

If payers created this crisis by removing clinical judgment from the denial process, the solution cannot be to remove it from the response.

What Human-in-the-Loop Actually Means

Human-in-the-loop (HITL) AI is not a compromise. It is a precision architecture that deploys AI where it has a structural advantage — pattern recognition, policy interpretation, documentation gap detection, evidence assembly — while preserving clinical judgment at every decision point that carries financial or patient care consequence.

In denial management, this plays out across three intervention points:

Pre-Submission

AI scans clinical documentation against payer-specific medical necessity criteria and flags gaps before the claim is filed. A clinician reviews flagged cases, adds context, and approves. The AI does the scanning. The clinician makes the call.

At Denial

AI generates a targeted appeal argument mapped to the specific payer, denial code, and clinical context. A nurse or physician reviews, edits if needed, and submits. The AI does the drafting. The clinician ensures clinical integrity and audit defensibility.

At Escalation

AI identifies which denied cases have the highest recovery probability and surfaces them for peer-to-peer review. The physician enters that conversation prepared, not scrambling. The AI does the triage. The clinician does the advocacy.

At each stage, AI compresses the administrative burden and reduces time-to-resolution. The human provides the contextual reasoning and accountability that payers, regulators, and patients require.

The Capacity Multiplier for Smaller Organizations

Large health systems have clinical documentation improvement specialists, denial management teams, and physician advisors on staff. They absorb the administrative burden — imperfectly, but with structural resilience.

Independent practices and rural hospitals cannot. A neurology practice managing prior authorizations for chronic migraine patients does not have a dedicated appeals team. A critical access hospital does not have a CDI specialist reviewing every chart before submission.

What they have are clinicians — already operating at capacity — being asked to do administrative work that directly competes with care delivery, clinician retention, and reimbursement predictability.

HITL AI changes the math. A single nurse can manage the appeal workload that previously required three. A physician advisor reviews cases that genuinely require clinical judgment, not every denial by default. Smaller organizations gain the analytical leverage of large systems without proportionally increasing administrative burden or headcount.

The Governance Case: Auditability Is Not Optional

There is a second reason full automation is the wrong goal — and it has direct implications for procurement decisions.

When an AI system generates and submits an appeal without human review, the organization assumes full liability for the clinical claims in that document. If a payer challenges the medical necessity argument, or if a CMS audit surfaces a pattern of unsupported appeals, there is no documented clinical review to point to.

HITL AI is the only model that produces an auditable chain of clinical accountability at each decision point. That is not a differentiating feature. It is a procurement requirement for any organization serious about compliance with evolving CMS and OIG oversight frameworks.

When evaluating any AI-assisted denial management platform, leaders should require clear answers to:

  • Where does the human touch the workflow, and what decision authority do they hold at that point?
  • Does the system produce an audit trail documenting clinical review at each consequential step?
  • Can the platform explain its flagging logic and appeal rationale in terms a payer reviewer will accept?
  • Is escalation logic transparent — and does the platform distinguish what it automates from what it surfaces for human judgment?

A platform that cannot answer these questions is not a denial management tool. It is a liability.

Building for the Long Term

The organizations investing in HITL infrastructure today are not just recovering denied revenue. They are building a durable operational capability — one that improves reimbursement predictability, reduces administrative burden on clinical staff, and creates defensible documentation practices that hold up under payer scrutiny.

That infrastructure does not require replacing existing teams. It requires giving those teams something they have never had: real-time policy intelligence, predictive visibility into denial risk, and the ability to address documentation gaps before they become revenue losses.

At Authsnap, this is the architecture we built from the ground up — because we have seen firsthand what happens when clinical judgment is removed from the denial management equation. The patient consequences are real. The financial consequences compound quietly. And the administrative burden falls disproportionately on the practices and systems least equipped to absorb it.

The right AI does not replace that clinical judgment. It protects it — and the clinicians who carry it.

Closing Thought

Full automation in denial management optimizes for throughput. Human-in-the-loop AI optimizes for outcomes — clinical outcomes, financial outcomes, and the patient access that depends on both.

The organizations that will remain financially resilient are those that treat denial prevention as a clinical operations strategy, not a back-office function. That means investing in infrastructure that reduces administrative burden on clinicians, improves margin protection through prevention rather than recovery, and produces the audit defensibility that regulators and payers increasingly require.

Human-in-the-loop AI is not a limitation on what technology can do.

It is the architecture of trust. And in healthcare, trust is the only foundation worth building on.

Wael Khouli, MD, MBA
Co-Founder & Chief Medical Officer, Authsnap
Helping neurology and specialty practices recover denied revenue and protect clinical time.

← Back to all insights